Tilray CEO on first earnings file and rising cannabis substitute

Tilray CEO on first earnings file and rising cannabis substitute

Tilray CEO Brendan Kennedy discusses his firm’s enhance alongside the expansion of the clinical pot substitute as a total.

You May Also Like

About the Author: Cannabis Action Network News

Leave a Reply

Your email address will not be published. Required fields are marked *